Evidence map›Paper›PMID 11559810›Full record

ArticleJournal of virology2001

Multiple effector functions mediated by human immunodeficiency virus-specific CD4(+) T-cell clones.

P J Norris, M Sumaroka, C Brander, H F Moffett, S L Boswell, T Nguyen, Y Sykulev, B D Walker, E S Rosenberg

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 71 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Cytotoxic CD4 T cells in antiviral immunity.Journal of biomedicine & biotechnology · 2011
    Review
  16. Article
  17. Article
  18. The importance of Foxp3 antibody and fixation/permeabilization buffer combinations in identifying CD4+CD25+Foxp3+ regulatory T cells.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2009
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

P J NorrisPartners AIDS Research Center and Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.
M Sumaroka
C Brander
H F Moffett
S L Boswell
T Nguyen
Y Sykulev
B D Walker
E S Rosenberg
Harvard University · USMassachusetts General Hospital · USThomas Jefferson University · USFenway Health · US

Funding

HIV 1 SPECIFIC CD4 CELLS IN DISEASE PATHOGENESISR01AI040873 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENBERG, ERIC S · 1997 to 2006
$1.8M
CHARACTERIZATION OF HIV-1-SPECIFIC T HELPER CELL CLONESK08AI001698 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI NORRIS, PHILIP J · 2000 to 2004
$598k
HIV-1 specific CD4 Cells in Disease PathogenesisR21AI040873 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENBERG, ERIC S · 2001 to 2001
$320k
VIRUS-SPECIFIC CD4 HELPER RESPONSES IN HIV1 INFECTIONK08AI001541 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI ROSENBERG, ERIC S · 1998 to 2000
$125k
NIAID NIH HHS AI01541NIAID NIH HHS AI01698-01NIAID NIH HHS AI40873NIAID NIH HHS K08 AI001698NIAID NIH HHS R01 AI040873NIAID NIH HHS R21 AI040873
6 · The paper itself

Abstract

Mounting evidence suggests that human immunodeficiency virus type 1 (HIV-1) Gag-specific T helper cells contribute to effective antiviral control, but their functional characteristics and the precise epitopes targeted by this response remain to be defined. In this study, we generated CD4(+) T-cell clones specific for Gag from HIV-1-infected persons with vigorous Gag-specific responses detectable in peripheral blood mononuclear cells. Multiple peptides containing T helper epitopes were identified, including a minimal peptide, VHAGPIAG (amino acids 218 to 226), in the cyclophilin binding domain of Gag. Peptide recognition by all clones examined induced cell proliferation, gamma interferon (IFN-gamma) secretion, and cytolytic activity. Cytolysis was abrogated by concanamycin A and EGTA but not brefeldin A or anti-Fas antibody, implying a perforin-mediated mechanism of cell lysis. Additionally, serine esterase release into the extracellular medium, a marker for cytolytic granules, was demonstrated in an antigen-specific, dose-dependent fashion. These data indicate that T helper cells can target multiple regions of the p24 Gag protein and suggest that cytolytic activity may be a component of the antiviral effect of these cells.

Indexed as

HIV-1MacrolidesAmino Acid SequenceAnti-Bacterial AgentsAntibodiesBrefeldin ACD4-Positive T-LymphocytesClone CellsCyclophilinsCytotoxicity, ImmunologicDose-Response Relationship, DrugEgtazic AcidEpitopesfas ReceptorHIV Core Protein p24HIV InfectionsAnti-Bacterial AgentsAntibodiesBrefeldin Aconcanamycin ACyclophilinsEgtazic AcidEpitopesfas ReceptorHIV Core Protein p24Interferon-gammaMacrolides

Identifiers

PMID11559810
PMCPMC114549
OpenAlexW2098481330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.